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In vivo detection of brain Krebs cycle intermediate by
hyperpolarized magnetic resonance
Mor Mishkovsky1,2, Arnaud Comment3 and Rolf Gruetter1,2,4
The Krebs (or tricarboxylic acid (TCA)) cycle has a central role in the regulation of brain energy regulation and metabolism, yet brain
TCA cycle intermediates have never been directly detected in vivo. This study reports the ﬁrst direct in vivo observation of a TCA
cycle intermediate in intact brain, namely, 2-oxoglutarate, a key biomolecule connecting metabolism to neuronal activity.
Our observation reveals important information about in vivo biochemical processes hitherto considered undetectable. In particular,
it provides direct evidence that transport across the inner mitochondria membrane is rate limiting in the brain. The hyperpolarized
magnetic resonance protocol designed for this study opens the way to direct and real-time studies of TCA cycle kinetics.
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INTRODUCTION
The connection between cerebral energy metabolism and neural
function was highlighted more than a century ago.1 Following
Krebs’ formulation, it became well established that the tricar-
boxylic acid (TCA) cycle is central to brain energy homeostasis,2 as
it is the ﬁnal common path for aerobic oxidation of any molecule
that can be transformed into an acetyl group (carbohydrates, fatty
acids, and amino acids). In addition, the cycle serves as a source of
biosynthetic precursors for synthesis of physiological amino acids.
Several crucial questions are, however, left unanswered, in
particular the regulation of the metabolism of glutamate (Glu),
the major excitatory neurotransmitter. Glutamate is in dynamic
exchange with the TCA cycle intermediate 2-oxoglutarate (2OG;
IUPAC nomenclature for a-ketoglutarate) through reactions that
are key to the regulation of cellular oxygen metabolism such as
the malate-aspartate shuttle, aspartate aminotransferase (AAT),
and glutamate dehydrogenase. A difﬁculty in addressing the
regulation of TCA cycle activity in vivo is rooted in the fact that the
concentrations of TCA cycle intermediates are too small to be
detectable using established in vivo methods such as magnetic
resonance (MR).3 To date, TCA cycle activity in vivo has been
exclusively studied using carbon-13 (13C) magnetic resonance
spectroscopy (MRS), a technique that enables the investigation of
metabolic processes in vivo in a non-invasive manner.4 Because of
the 13C low natural abundance of B1%, this type of experiment
requires the infusion of a suitable 13C-labeled precursor, which
leads to the distribution of the 13C-label among the metabolic
products and allows probing speciﬁc pathways.5–7 The turnover of
the label from precursors to products is typically measured from
the time course of 13C concentration changes readily quantiﬁable
from the 13C MR spectrum of the many available precursors.
13C-labeled acetate has been used to investigate the TCA cycle
rates using MRS. Acetate has the advantage of being readily taken
up by the brain and as it is solely metabolized in astrocytes, it has
been used as a tracer to study glial metabolism in vivo in rats8–10
and in humans.11 However, most of the molecules that become
labeled as a consequence of the acetate infusion cannot be
detected by MR in vivo because of their low concentration and the
relatively low sensitivity of in vivo MR. Only the most concentrated
amino acids, e.g., Glu, glutamine, and aspartate can be detected
in vivo.3–5,12 These amino acids are not part of the TCA cycle but
indirectly reﬂect TCA cycle activity because of label incorporation
from TCA cycle intermediates, namely, 2OG and oxaloacetate.
The assumption required for determining TCA cycle ﬂux through
13C isotopomer analysis is that the relative concentration of 13C
isotopomers is identical in precursors and their detectable
metabolic products.13 In addition, dynamical analysis through
this method is only representative of the TCA cycle kinetics if the
exchange rate between TCA intermediates and products is at least
on the same order of magnitude as the TCA cycle ﬂux. Therefore,
the direct detection of TCA cycle intermediates would provide
new crucial information concerning the kinetics of the label ﬂow
through the TCA cycle.
MATERIALS AND METHODS
Dynamic Nuclear Polarization of 13C-labeled Acetate
The 13C nuclear spins in frozen glassy solutions of sodium [1-13C]acetate
or sodium [1,2-13C2]acetate (Sigma-Aldrich, Buchs, Switzerland) were
dynamically polarized using a custom-designed DNP polarizer operating
at 5 T and 1±0.05 K as described in earlier publications.14,15 A 4.5mol/L
solution of sodium [1-13C]acetate or sodium [1,2-13C2]acetate dissolved in a
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2/1 (vol/vol) D2O/d6-ethanol (Cambridge Isotope Laboratories, Andover,
MA, USA) containing 33mmol/L of TEMPO nitroxyl radical (2,2,6,6-
tetramethyl-1-piperidinyloxy, Sigma-Aldrich) was prepared. Droplets of
solution were plunged in liquid nitrogen to form frozen beads of B2mm
diameter. A volume of 0.4ml of frozen solution was placed inside the DNP
polarizer sample holder, which was then inserted into the microwave
cavity located within the cryostat ﬁlled with B0.5 L of liquid helium at
atmospheric pressure (4.2 K). The vacuum pump system was then turned
on to lower the temperature of the sample space such as to maintain the
frozen sample under superﬂuid helium at 1±0.05 K.
The microwave power at the output of the source was set to 40mW and
the irradiation frequency was set to 139.85GHz. The nuclear polarization
was monitored as a function of time by means of pulsed nuclear magnetic
resonance using 51 tipping pulses. Once the polarization of the 13C nuclei
had reached a targeted value (the 13C solid-state polarization reached
12±2% after 2±0.4 hours in sodium [1-13C]acetate samples and after
1±0.2 hours in sodium [1,2-13C2]acetate samples), the frozen solution was
dissolved in 5ml of superheated D2O (170 1C) by means of a dissolution
apparatus similar to the one described by Ardenkjaer-Larsen et al.16 In the
system used for the present study, a helium gas stream drove the resulting
solution out of the polarizer magnet through a 5-m long capillary into the
bore of an animal imager, where the sample was collected in a remotely
controlled infusion pump that separated the liquid solution from the gas,
and infused a chosen amount of liquid solution into an animal.14 Note that
the solution contained a residual 2mmol/L TEMPO radical, but its effect on
acetate 13C T1 is negligible.
17 The delay between dissolution and infusion
was set to 3 seconds.
Animal Preparation
All animal experiments were conducted according to federal and local
ethical guidelines, and the protocols were approved by the local regulatory
body of the Canton Vaud, Switzerland (Service de la consommation et des
affaires ve´te´rinaires, Affaires ve´te´rinaires, Canton de Vaud, Suisse).
In vivo experiments were performed on male Sprague–Dawley rats
(B450 g). Animals were anesthetized with 1.5% isoﬂurane in a 30%
O2/70% N2O mixture. A femoral vein was catheterized for acetate infusion.
The rat was placed on a holder along with the infusion pump and the
femoral vein catheter was connected to the outlet of the pump. The holder
was then inserted inside the scanner. A bolus ofB2.2ml of hyperpolarized
solution containing B0.3mol/L of the 13C-labeled acetate was infused
within 9 seconds. It contained a residual TEMPO concentration of
B2mmol/L and 2% of deuterated ethanol. Such concentrations should
not affect cerebral metabolism within the time frame of our experiments.
As mentioned by Sano et al,18 most commercially available nitroxyl radicals
are water-soluble and cannot pass through the blood–brain barrier. It was
also showed in a recent in vivo 13C MRS study that the cerebral metabolism
observed after the infusion of [1-13C]ethanol in rats at an B10-fold higher
concentration than used in the present study is very similar to the
metabolism observed after the injection of [1-13C]acetate as a consequence
of the conversion of ethanol to acetate in the liver and subsequent
recirculation of acetate into the brain.19 In our study, only B1% of the
13C’s come from residual ethanol. Rat physiology was monitored during the
experiments: body temperature was kept between 37 1C and 38 1C while
respiration rate was maintained at 60 per min by adjusting the isoﬂurane
level in respiratory gases. The rate and dose of the infusion was determined
in bench experiments to insure that the bolus-like infusion is not lethal for
rats. The blood volume for a 450-g rat isB28mL.20 Taking into account that
sodium concentration in the blood is B150mmol/L, a bolus injection of
2.2mL with a concentration of 300mmol/L of sodium acetate will lead to a
sodium plasma concentration of B160mmol/L further attenuated during
the time course by exchange with interstitial ﬂuid. As the recorded
physiological parameters (temperature, respiration rate as well as blood pH
during the preparatory experiments) were stable throughout the
experiments, we considered that this modest temporary increase in Naþ
concentration had no inﬂuence on animal physiology. As shown by Lien
et al,21 no variations in brain metabolite concentrations such as Glu
concentration were observed within 2 hours of acute hypernatremia (serum
sodium 194±5mmol/L). We do not expect that any change can occur
within a minute after the injection of the bolus. At the end of the
experiment, animals were killed with an overdose of pentobarbital.
Magnetic Resonance Imaging and MRS Experiments
All measurements were performed on a Varian INOVA spectrometer
(Varian, Palo Alto, CA, USA) interfaced to a 31-cm horizontal-bore actively
shielded 9.4 T magnet (Magnex Scientiﬁc, Abingdon, UK). Radiofrequency
(RF) transmission and reception was done using a home-built hybrid
surface coil consisting of a proton quadrature coil and a three-loop 10-mm
diameter carbon coil. This coil was placed on top of the rat head. The 13C
spectra were acquired through single-pulse experiments with 301 BIR-4
adiabatic radiofrequency pulses to compensate for B1 inhomogeneities.
22
Localization was achieved using an outer volume suppression scheme23
with voxels volume of 343mL (7.3 9.4 5mm3). The time course
measurements were acquired in a voxel of 275mL (5 5 5mm3) using
a series of 301 pulse applied every 3 seconds. The acquisition time was set
to 200ms. To generate an external reference signal, a small sphere ﬁlled
with 99% 13C-labeled formic acid was placed in the center of the carbon
coil. High-order shimming was performed using the FASTESTMAP
algorithm.24 Data were processed using MATLAB. To perform homo-
nuclear polarization transfer between the two 13C spins of acetate, we used
a speciﬁc pulse sequence consisting of a single-voxel localization
scheme (7.3 9.4 5mm3) followed by three 901 radiofrequency pulses.25
RESULTS
Dissolution dynamic nuclear polarization (dissolution DNP),16
a hyperpolarization technique based on low-temperature
microwave-driven polarization transfer from the electron spins
of paramagnetic centers to precursors nuclear spins26 and provi-
ding an increase in MR sensitivity of up to four orders of magni-
tude, was implemented as follows: low-temperature DNP was
performed in superﬂuid helium at 1±0.05 K using a home-built
5 T polarizer coupled to a 9.4-T animal scanner14,15 and, 3 seconds
after dissolution, 13C-labeled hyperpolarized acetate (13C polari-
zation of 12±2%) was injected in the rats femoral vein before
MRS measurements. The hyperpolarized 13C signal was detectable
over a time period on the order of the characteristic time T1
required for the spin magnetization to return to its thermal
equilibrium value. The in vivo 13C characteristic signal decay time
after bolus injection of the hyperpolarized [1-13C]acetate solution
was deduced by ﬁtting the signal amplitude (corrected for the
effect of the radiofrequency pulses) with a decaying mono-
exponential function and was determined to be 15±2 seconds in
the rat head (n¼ 4; data not shown).
To selectively measure the 13C signal from the brain, a locali-
zation pulse sequence was used in conjunction with a surface
coil.23 A 13C spectrum observed in the brain 16 seconds after
dissolution (Figures 1A and 1B) delineates two peaks separated by
0.15 p.p.m., which were detected in all animals (n¼ 3). The more
intense signal (182.2 p.p.m.) was unambiguously assigned to the
carboxyl 13C of the injected acetate molecule.27 The less intense
resonance at 182.05 p.p.m. likely originated from a metabolic
product of acetate. The chemical shift of 182.05 p.p.m. is within
8Hz of the reported in vitro value of the 5-13C resonance of
[5-13C]2OG.27 Observing the incorporation of [1-13C]acetate into
[5-13C]2OG should imply, considering the well-established meta-
bolic pathways of acetyl-CoA metabolism in the TCA cycle, that
the creation of [4,5-13C2]2OG from [1,2-
13C2]acetyl-CoA is detect-
able. Therefore, a second set of experiments (n¼ 3) was per-
formed under identical conditions, except that [1,2-13C2]acetate
was infused. The interaction between the two adjacent 13C nuclear
spins through their chemical bonds leads to a splitting of their
resonance peak into two lines (J-coupling) that are separated
according to the strength of the interaction. The spectra
presented in Figures 2A and 2C show that the acetyl moiety is
indeed incorporated into the observed metabolite, as its
resonance is split into two lines separated by a frequency
corresponding to 13C–13C J-coupling, as is the case for the
precursor acetate resonance. This result implies that the acetyl
moiety remained intact through the metabolic processes leading
to its incorporation into the observed metabolite.
To provide even further evidence for the metabolite assign-
ment, a custom-tailored adiabatic polarization transfer sequence
was developed and designed for this particular study.25 Before
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detection, the enhanced carboxyl 13C polarization was transferred
to the aliphatic 13C spins, which exhibit large chemical shift
dispersion. Although both the carboxyl and the aliphatic 13C
polarizations are enhanced through DNP, the aliphatic 13C will not
remain hyperpolarized in vivo because of its short T1 relaxation
time on the order of 2 seconds. This was veriﬁed in three
experiments, in which no [2-13C]acetate signal was observable
before polarization transfer. To ensure that the same stage of the
metabolic process was probed, the time interval between
dissolution and data acquisition was set as in the previous
measurement to 16 seconds. The spectra recorded in the
aliphatic region after the polarization transfer are presented in
Figures 2B and 2D. The two resonances observed were assigned to
acetate (24.5 p.p.m.) and 2OG (36.0 p.p.m.), which is consistent
with the carboxyl spectra (Figures 2A and 2C). From the results
described above, we conclude that the metabolite observed
in the brain after the injection of hyperpolarized acetate is
indeed 2OG.
Figure 1. In vivo localized 13C spectra measured with a 301 adiabatic pulse applied 4 seconds after the completion of the infusion of
hyperpolarized [1-13C]acetate. The single scan experiment (A) and the sum over three single scan experiments performed in three different
animals (B) were obtained by selectively detecting the 13C signal in the area delimited in blue. Please see full text version for color figures.
Figure 2. (A, C) In vivo localized 13C spectra measured with a 301 adiabatic pulse applied 4 seconds after the completion of the infusion of
hyperpolarized [1,2-13C2]acetate. The single scan experiment (A) and the sum over three single scan experiments performed in three different
animals (C) were obtained by selectively detecting the 13C signal in the area delimited in blue. (B, D) In vivo localized 13C spectra measured
with a 901 adiabatic pulse applied 4 seconds after the completion of the infusion of [1,2-13C2]acetate and after carbon–carbon polarization
transfer. The single scan experiment (B) and the sum over three single scan experiments performed in three different animals (D) were
obtained by selectively detecting the 13C signal in the area delimited in blue. Please see full text version for color figures.
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The time evolution of the acetate and 2OG signal integrals (data
measured on four different animals) is presented in Figure 3.
We observed that the maximum signal of 2OG is delayed by
2±0.5 seconds as compared with the maximum signal of acetate.
Note that the small ratio between acetate and 2OG signals
(2.2±0.3) suggests that the concentration of [1-13C]acetate inside
the brain is low at the time of the measurements.
DISCUSSION
To the best of our knowledge, this is the ﬁrst time 2OG is directly
observed in vivo in brain. We are not aware of any report
describing the detection of 2OG using non-hyperpolarized MR
including our own attempts, which implies either an upper
concentration limit on the order of 0.1 mmol/g (MR detection limit)
or that the intermediate is predominantly in a bound state
characterized by a broad and thus unobservable MR signal.
Indeed, based on recent structural investigations noting a close
colocalization of the TCA cycle enzymes, the proposal has
emerged that some, if not all, TCA cycle enzymes may operate
in vivo as a single unit (metabolon).28–30 The present study shows
that at least a sizable portion of 2OG (an estimation is given
below) is sufﬁciently mobile to be detected by dissolution DNP
MR. From recent results on acetate transport in the rat brain
reporting Michaelis–Menten parameters, VmaxB1 mmol/g/min
and KM¼B4mmol/L in the study by Deelchand et al9 or
VmaxB1.3 mmol/g/min and KM¼B27mmol/L in the study by
Patel et al,10 we can estimate that the acetate concentration
20 seconds after the injection is on the order of 0.28 or 0.19mmol/g,
respectively. The average ratio of 2.2±0.3 between the
[1-13C]acetate and [5-13C]2OG signal integrals measured in the
present study (Figure 3) thus suggest that the 2OG concentration
in the brain is between 0.28/2.2¼ 0.125 mmol/g and 0.19/2.2¼
0.085 mmol/g, which is comparable with the values given by
Siesjo¨.31 In fact, as 2OG participates in at least three distinct
mitochondrial reactions, namely, 2OG dehydrogenase , glutamate
dehydrogenase, and AAT, it is unlikely that all enzymes can
simultaneously bind to 2OG. We further conclude that as the
enhanced polarization must be preserved during the four
enzymatic steps between acetyl-CoA and 2OG (Figure 4), all other
TCA cycle intermediates, in particular glial citrate, are present at
either a much lower concentration than 2OG or in a predomi-
nantly bound state.
The 13C label transfer from mitochondrial TCA cycle inter-
mediate to cytosolic amino acid, in particular Glu, is mediated at
least in part by the malate-aspartate shuttle thought to operate at
the rate of mitochondrial AAT.7 Assuming rapid mitochondrial AAT
action in astrocytes, one would expect to observe a signiﬁcant Glu
signal. Indeed, assuming a glial Glu concentration ofB1 mmol/g
and taking a reported transamination rate ofB50mmol/g/min,7
the turnover time of Glu should be on the order of 1 seconds,
which is signiﬁcantly shorter than the [1-13C]Glu T1 (B17 seconds
in perfused heart).32 It has, however, been suggested that the Glu-
aspartate antiporter, known to be rate-limiting for malate-
aspartate shuttle, may operate at much lower rates, close to
those of the TCA cycle.5 The absence of Glu signal indeed
indicates a slow exchange of label between 2OG and Glu, whether
mediated by AAT alone or malate-aspartate shuttle. Assuming a
linear fractional enrichment of 2OG from 0% to 100% within the
20 seconds of the experiment, we deduced that the maximum
concentration of [5-13C]Glu after 20 seconds is given by the
integration over time of t/20  Vx mmol/g between t¼ 0 and
t¼ 20 seconds, where Vx is the transmitochondrial label exchange
(the dilution of 2OG by the Glu pool is not taken into account).
Taking Vx¼ 0.17±0.01 mmol/g/min,33 we deduce that the
[5-13C]Glu concentration should be at most 0.028±0.003 mmol/g,
which seems to be below our detection level as no signiﬁcant Glu
Figure 3. Time evolution of the acetate and 2-oxoglutarate (2OG)
signal integrals. The spectra shown in the main figure were
measured in a single experiment with a series of 301 adiabatic
pulse applied every 3 seconds starting after the completion of the
infusion. The signal-to-noise ratio of the maximum 2OG was 25±5.
The average ratio between the acetate and the 2OG signal integrals
over the entire measurement time was deduced to be 2.2±0.3 in all
four experiments using the JMRUI software.44 The open and full
circles correspond to the average values of the normalized signal
integrals measured in four different animals. The continuous and
dotted lines are only drawn as a guide for the eyes and are not
deduced from a fit to a model.
Figure 4. Sketch of the glial metabolic processes involving the
infused hyperpolarized acetate molecules. The acetate molecules
diffuse in the brain and are taken up by the astrocytes before
being metabolized in the mitochondria, leading to the creation of
2-oxoglutarate (2OG) through the tricarboxylic acid (TCA) cycle.
The chemical structure of the observed hyperpolarized molecules is
drawn and their names are highlighted in red. Please see full text
version for color figures.
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signal could be observed even after averaging the signals (Figures
1B, 2C and 2D). The fact that citrate was not observed implies that
the glial citrate concentration is very low or too broad to be
detected. It is of interest to note that recent studies have
suggested a very low expression of the Glu-aspartate antiporter in
astrocytes.34
We conclude from the novel observation of 2OG signal and the
lack of Glu signal that the reactions leading to 13C-label
incorporation into Glu are operating, in the glial compartment
in vivo, at a rate much lower than that of transaminase, thus
implying that transport across the inner mitochondria membrane
is rate limiting. More generally, the present study illustrates the
potential of hyperpolarized acetate as a precursor to non-
invasively directly probe glial TCA cycle activity and thus detect
pathological alterations hitherto inaccessible to direct observation.
The direct determination of TCA cycle intermediates bears the
potential to determine TCA cycle rate without the need to assess
the conversion and transport of 2OG to glutamate. Several
previous in vivo studies showed that the hyperpolarized state of
13C-labels survives metabolic reactions.35–38 Here, we note that the
13C polarization is still largely enhanced after as many as four
enzymatic reaction steps. Marjan´ska et al39 did not observe 2OG in
the rat brain after the injection of hyperpolarized [2-13C]pyruvate,
which may be because of the additional reactions implicated, for
example, ﬂux through pyruvate dehydrogenase, or to slow
transport.
These results show the feasibility of probing the real-time
kinetics of the transformation of a fuel into a TCA cycle
intermediate in vivo in the brain. Recent progress showed that
the ability of probing real-time metabolism in vivo could become
crucial in cancer research.35,38 In the context of the present study,
it is of particular interest to note that a large fraction of gliomas,
the most common brain tumor type in humans, are associated
with genetic mutations in the isocitrate dehydrogenase enzyme
affecting the metabolism of isocitrate and giving the enzyme the
ability to produce 2-hydroxyglutarate.40,41 As the metabolic ﬂux
from acetate to 2OG should be affected by variations in the
conversion rate between isocitrate and 2OG, the new
hyperpolarized MR protocol presented in this report could
potentially be used to detect in vivo effect of the mutations on
the metabolic rates. In addition, as a dramatic reduction of the
isocitrate dehydrogenase as well as 2OG dehydrogenase activities
were observed in numerous brain disorders,42 in particular in
Alzheimer’s disease patients,43 the ability to measure the 13C
labeling of the 2OG pool in real time could give this metabolite
the status of a sensitive biomarker for neurological dysfunctions.
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